Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine intranasal spray plus intravenous lidocaine for prevention of postoperative delirium after laparoscopic radical gastrectomy in older adults
ChiCTR2600132930Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and lidocaine in postoperative delirium (POD) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Incidence of postoperative delirium within 4 days after surgery. Planned start May 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocaine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600132930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132930.